CTM
Castellum, Inc.
CTM has lower modeled downside risk, despite its lower overall score.
INTC
Intel Corporation
INTC has the edge over CTM overall, supported by stronger fundamentals and stronger modeled upside.
CTM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Weak |
CTM's revenue and cash flow are currently stable, but its profitability and balance sheet are under pressure.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
CTM PE Valuation
CTM has no meaningful PE right now: it lost money over the past year.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
CTM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Stable | |
| -- | |
| Limited | |
| High |
Analysts expect CTM's earnings to decline, with its revenue and profitability holding steady.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
CTM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.02 | — |
| Q3 2026 | -$0.04 | +$0.02 |
| Q2 2026 | -$0.03 | +$0.05 |
| Q1 2026 | -$0.02 | +$0.09 |
| Q4 2025 | -$0.03 | +$0.15 |
| Q3 2025 | -$0.06 | +$0.12 |
| Q2 2025 | -$0.08 | +$0.27 |
| Q1 2025 | -$0.11 | +$0.25 |
| Q4 2024 | -$0.18 | +$0.20 |
CTM has the edge over INTC on earnings, with more consistent year-over-year improvement.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.
CTM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $14.7M | +0.6% |
| Q2 2026 | $13.9M | -1.1% |
| Q1 2026 | $14.3M | +23% |
| Q4 2025 | $12.6M | +22% |
| Q3 2025 | $14.6M | +26% |
| Q2 2025 | $14M | +22% |
| Q1 2025 | $11.7M | +2.9% |
| Q4 2024 | $10.3M | -7.1% |
CTM has the edge over INTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.8% | -6.9 points |
| Q2 2026 | -7.9% | -5.2 points |
| Q1 2026 | -4.9% | +7.9 points |
| Q4 2025 | -11% | +4.7 points |
| Q3 2025 | 3% | +15 points |
| Q2 2025 | -2.7% | +11 points |
| Q1 2025 | -13% | +11 points |
| Q4 2024 | -16% | -1.9 points |
CTM's operating margin was −3.8% last quarter, down 6.9 points from the same quarter a year ago.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over CTM on profitability, with a higher operating margin.
CTM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.3M | -234% |
| Q1 2026 | $1.3M | +$3.8M |
| Q4 2025 | -$671.5K | -$277.1K |
| Q3 2025 | $957K | +30% |
| Q1 2025 | -$2.5M | -10647% |
| Q4 2024 | -$394.4K | -145% |
| Q3 2024 | $738.9K | +$2M |
| Q2 2024 | $748.6K | +33% |
CTM's free cash flow has turned positive again: $366,940 over the past year, against −$1M the year before.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over CTM on cash generation, producing positive trailing cash flow while its opponent burns cash.
CTM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +138K shares |
| 1 year | +5.6% | +5.1M shares |
| 3 years | +96% | +46.5M shares |
| 5 years | +515% | +79.4M shares |
| Available history | +543% | +80.1M shares |
CTM has the edge over INTC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has 5.3B diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
CTM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2021 | 29.1x | High |
| Q1 2021 | 11.1x | High |
CTM's net debt is more than 20 years of its operating earnings (EBITDA).
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
CTM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 14.3 | Oversold |
CTM's weekly RSI is 36 (neutral) and its Stochastic is 14 (oversold).
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
CTM PE vs Technology Sector
CTM has no meaningful PE right now: it lost money over the past year.
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
CTM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.54 | 17% below |
| 20 week MA | $0.60 | 25% below |
| 50 week MA | $0.74 | 39% below |
| 100 week MA | $0.91 | 51% below |
| 200 week MA | $0.67 | 33% below |
CTM is in a downtrend: it's below all five of its weekly moving averages, and 33% below its 200-week average.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has the edge over CTM on trend strength, trading above more of its moving averages.
CTM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $1.47 | $1.22 | -17% |
| 2023 | $1.22 | $0.30 | -75% |
| 2024 | $0.30 | $1.42 | +373% |
| 2025 | $1.42 | $1.03 | -27% |
| 2026 YTD | $1.03 | $0.45 | -56% |
CTM's yearly returns have swung widely, from +373% in 2024 to −75% in 2023. It's down 56% so far in 2026.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over CTM on returns for 2026, with the stronger performance.